About: Safety and Efficacy of Pimecrolimus Cream 1% in Atopic Disease Modification

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Safety and Efficacy of Pimecrolimus Cream 1% in Atopic Disease Modification Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

clinical trial

Attributes	Values
rdf:type	Item
description	clinical trial (en) ensayu clínicu (ast) klinisch onderzoek (nl) клінічне випробування (uk)
rdfs:label	Safety and Efficacy of Pimecrolimus Cream 1% in Atopic Disease Modification (en) Safety and Efficacy of Pimecrolimus Cream 1% in Atopic Disease Modification (nl)
skos:prefLabel	Safety and Efficacy of Pimecrolimus Cream 1% in Atopic Disease Modification (en) Safety and Efficacy of Pimecrolimus Cream 1% in Atopic Disease Modification (nl)
name	Safety and Efficacy of Pimecrolimus Cream 1% in Atopic Disease Modification (en) Safety and Efficacy of Pimecrolimus Cream 1% in Atopic Disease Modification (nl)
title	wds:Q66031613-A19714C0-F7EA-489F-B5C5-6315037DC5F8
title	An Investigation of the Safety and Efficacy of Elidel® 1% Cream in Atopic Disease Modification, Assessed in a 3-year Randomized Double-blind Vehicle Controlled Phase to Evaluate Effects on Atopic Dermatitis in Infants, and a 2-3 Year Open-label Phase to Evaluate the Effect of Early Intervention Versus Delayed Intervention With Elidel® on the Incidence of Asthma in Children (en)
end time	wds:Q66031613-1B56B03C-B03D-485F-A213-EA4ACD4E7CD1
end time	2008-01-01 00:00:00Z (xsd:dateTime)
instance of	wds:Q66031613-CCBCA123-958E-42B7-A653-4FB69A2FB9EA
instance of	clinical trial
start time	wds:Q66031613-781EAC0C-F7BF-4707-8B13-795E08C2EB61
start time	2003-10-01 00:00:00Z (xsd:dateTime)
country	wds:Q66031613-92AD7917-B772-4834-B165-617F349826DC
country	United States of America
research site	wds:Q66031613-03824E9B-5FFD-4B66-A9D3-03DF124DE09C wds:Q66031613-4BEDDC96-59F1-4787-914A-DBD0CD46AA3C wds:Q66031613-75E71B0C-04D1-4169-B018-1A9E61B51122
research site	Children's Hospital of Orange County Allegheny General Hospital Tennessee Clinical Research Center
minimum age	wds:Q66031613-DEF5AB64-1D51-400D-8FA1-331C81208C8C
minimum age	3 (xsd:decimal)
medical condition	wds:Q66031613-C55984A0-9CCE-49D3-8B6D-CA40A305D16B wds:Q66031613-CADFF591-76FB-44AE-85B2-D700CF10DCEE
sponsor	wds:Q66031613-73175EF2-5CA4-459F-8A85-9FF5F228F2DD
medical condition	eczema dermatitis
sponsor	Novartis
number of participants	wds:Q66031613-05132E30-0569-481F-9918-AB6EB9450936
number of participants	1091 (xsd:decimal)
maximum age	wds:Q66031613-A01FC65F-401C-4D6E-8F54-D45CA722ACCA
maximum age	18 (xsd:decimal)
study type	wds:Q66031613-01725D13-35A4-4B0D-A0C9-00A2A358530A
study type	interventional study
ClinicalTrials.gov ID	wds:Q66031613-7C8114CF-FA4B-448C-9A5E-F2224E019BA7
ClinicalTrials.gov ID	NCT00124709
clinical trial phase	wds:Q66031613-56155FB6-1764-4982-86DF-C08288E49D56
clinical trial phase	phase IV clinical trial
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q66031613

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software